Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fibrocytes in Chronic Periaortitis: A Novel Mechanism Linking Inflammation and Fibrosis.
Nicastro M, Vescovini R, Maritati F, Palmisano A, Urban ML, Incerti M, Fenaroli P, Peyronel F, Benigno GD, Mangieri D, Volpi R, Becchi G, Romagnani P, Corradi D, Vaglio A. Nicastro M, et al. Among authors: peyronel f. Arthritis Rheumatol. 2019 Nov;71(11):1913-1922. doi: 10.1002/art.41024. Epub 2019 Sep 30. Arthritis Rheumatol. 2019. PMID: 31233292
Clinical and Prognostic Significance of Serum IgG4 in Chronic Periaortitis. An Analysis of 113 Patients.
Maritati F, Rocco R, Accorsi Buttini E, Marvisi C, Nicastro M, Urban ML, Fenaroli P, Peyronel F, Benigno GD, Palumbo AA, Corradi D, Emmi G, Pipitone N, Palmisano A, Vaglio A. Maritati F, et al. Among authors: peyronel f. Front Immunol. 2019 Apr 4;10:693. doi: 10.3389/fimmu.2019.00693. eCollection 2019. Front Immunol. 2019. PMID: 31019511 Free PMC article.
Rituximab for chronic periaortitis without evidence of IgG4-related disease: a long-term follow-up study of 20 patients.
Urban ML, Maritati F, Palmisano A, Fenaroli P, Peyronel F, Trivioli G, Ferretti S, De Biase C, Grayson PC, Pegoraro F, Prisco D, Romagnani P, Emmi G, Vaglio A. Urban ML, et al. Among authors: peyronel f. Ann Rheum Dis. 2020 Mar;79(3):433-434. doi: 10.1136/annrheumdis-2019-216258. Epub 2019 Nov 19. Ann Rheum Dis. 2020. PMID: 31744824 No abstract available.
Long-term follow-up of mTOR inhibition for Erdheim-Chester disease.
Pegoraro F, Maniscalco V, Peyronel F, Westenend PJ, Hendriksz TR, Roperto RM, Palumbo AA, Sieni E, Romagnani P, van Bommel EFH, Vaglio A. Pegoraro F, et al. Among authors: peyronel f. Blood. 2020 May 28;135(22):1994-1997. doi: 10.1182/blood.2019004478. Blood. 2020. PMID: 32299103 Free article. No abstract available.
IgG4-related disease: a clinical perspective.
Maritati F, Peyronel F, Vaglio A. Maritati F, et al. Among authors: peyronel f. Rheumatology (Oxford). 2020 May 1;59(Suppl 3):iii123-iii131. doi: 10.1093/rheumatology/kez667. Rheumatology (Oxford). 2020. PMID: 32348524 Review.
FCGR3B polymorphism predicts relapse risk in eosinophilic granulomatosis with polyangiitis.
Alberici F, Bonatti F, Adorni A, Daminelli G, Sinico RA, Gregorini G, Marvisi C, Fenaroli P, Peyronel F, Maritati F, Palmisano A, Urban ML, Percesepe A, Emmi G, Martorana D, Vaglio A. Alberici F, et al. Among authors: peyronel f. Rheumatology (Oxford). 2020 Nov 1;59(11):3563-3566. doi: 10.1093/rheumatology/keaa134. Rheumatology (Oxford). 2020. PMID: 32375167 No abstract available.
41 results